ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

ASCO 2012: Michael Link’s Presidential Address, and the 2012 Award Winners

June 8, 2012

UCLA, NYU Get Money, Near comprehensive Identification

May 30, 1975

Obama Picks Hamburg for FDA Commissioner

March 20, 2009

USC Scientists Says It’s Time Nobelists Recognize Value of Cancer Program

February 10, 1978

Cancer Center Directors Say Collaboration, Funding, and Application of Best Practices Will Reduce the Burden of Cancer.

September 15, 2006

Loeb Named ACS President, Eyre President Elect

November 14, 1986